Dernière mise à jour : 06 mai 2020
CADTH has received the following notice(s) of pending drug submission(s).
Marque de commerce | TBC |
---|---|
Nom générique | étonogestrel |
Fabricant | Merck Canada Inc. |
Indication(s) | Prévention de la grossesse |
Numéro de projet | SR0648-000 |
Demande de rétroaction des patients | 2020-05-06 |
Appel d'observations des patients fermé | 2020-06-25 |
Soumettre des observations | Soumettre |
S’inscrire en tant que clinicien expert | Inscription |
- If you are interested in contributing, more information can be found at CADTH Common Drug Review Patient Input and when you are ready to provide input, click on ‘Submit”.
- If you are interested in participating as a clinical expert, more information can be found at Clinical Expert involvement in CADTH’s Common Drug Review and Optimal Use of Drugs. If you are interested in participation, please click on “Register”.
Dernière mise à jour : 06 mai 2020